zoledronic acid

Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone

Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid

Zoledronic Acid for Prevention of Bone Loss After BAriatric Surgery (ZABAS)

Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic Amenorrhea

Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone

Effect of Local Subperiosteal Zoledronic Acid Injection on the Survival of Orthodontic Miniscrews

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

Zoledronic Acid Treatment in Patients With Congenital Dyserythropoietic Anemia

Romosozumab Use to Build Skeletal Integrity

FARE Augmentation of Proximal Femoral Fractures With CaS/HA and Systemic ZA

Muscle Impact of Treating Osteoporosis

Prevention of Bone Loss After Acute SCI by Zoledronic Acid

Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial

Denosumab to Prevent High-Turnover Bone Loss After Bariatric Surgery

Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma

Hypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic Cancer

Safety and Activity of IMAB362 in Combination With Zoledronic Acid and Interleukin-2 in CLDN18.2-positive Gastric Cancer

Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer

Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients